| Molecular Medicine | |
| Nuclear receptors: a bridge linking the gut microbiome and the host | |
| Wei-Dong Chen1  Zixuan Wang2  Yan-Dong Wang2  | |
| [1] Key Laboratory of Molecular Pathology, Key Laboratory of Receptors-Mediated Gene Regulation and Drug Discovery, School of Basic Medical Science, Inner Mongolia Medical University, Hohhot, Inner Mongolia, People’s Republic of China;School of Medicine, Key Laboratory of Receptors-Mediated Gene Regulation, The People’ Hospital of Hebi, Henan University, Henan, People’s Republic of China;State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, People’s Republic of China; | |
| 关键词: Gut microbiome; Nuclear receptors; Inflammatory bowel disease; Obesity; Diabetes; | |
| DOI : 10.1186/s10020-021-00407-y | |
| 来源: Springer | |
PDF
|
|
【 摘 要 】
BackgroundThe gut microbiome is the totality of microorganisms, bacteria, viruses, protozoa, and fungi within the gastrointestinal tract. The gut microbiome plays key roles in various physiological and pathological processes through regulating varieties of metabolic factors such as short-chain fatty acids, bile acids and amino acids. Nuclear receptors, as metabolic mediators, act as a series of intermediates between the microbiome and the host and help the microbiome regulate diverse processes in the host. Recently, nuclear receptors such as farnesoid X receptor, peroxisome proliferator-activated receptors, aryl hydrocarbon receptor and vitamin D receptor have been identified as key regulators of the microbiome-host crosstalk. These nuclear receptors regulate metabolic processes, immune activity, autophagy, non-alcoholic and alcoholic fatty liver disease, inflammatory bowel disease, cancer, obesity, and type-2 diabetes.ConclusionIn this review, we have summarized the functions of the nuclear receptors in the gut microbiome-host axis in different physiological and pathological conditions, indicating that the nuclear receptors may be the good targets for treatment of different diseases through the crosstalk with the gut microbiome.
【 授权许可】
CC BY
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO202112048297595ZK.pdf | 1038KB |
PDF